Results 61 to 70 of about 21,170 (204)
Success of transition to adult care in patients with pediatric‐onset chronic liver disease
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.Abstract Objectives Previous studies on chronic pediatric‐onset conditions have highlighted the risks of loss to follow‐up, disease progression, or therapeutic nonadherence during transition. However, very few studies have focused on liver diseases.
Sarah Mongbo +8 more
wiley +1 more source
Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3
Cancer Management and Research, 2019 Zhenqin Luo, Peiguo Cao Oncology Department, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, People’s Republic of ChinaCorrespondence: Peiguo CaoOncology Department, The Third Xiangya Hospital of Central South ...
Luo Z, Cao P
doaj
Metastatic hepatoblastoma: a rare cause of lung mass in adults
The Egyptian Journal of Bronchology, 2016 Hepatoblastoma is a pediatric malignant tumor of the liver with very few cases reported in adults. There are no case reports on isolated metastatic lung involvement with hepatoblastoma in an adult who had been previously treated for the pediatric form of
Hinesh N. Upadhyay +4 more
doaj +1 more source
Extracellular Vesicles in Hepatobiliary Malignancies [PDF]
, 2018 Primary hepatobiliary malignancies include a heterogeneous group of cancers with dismal prognosis, among which hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and hepatoblastoma (HB) stand out.
Aranburu, Aitziber +6 more
core +2 more sources
Clinical risk stratification of children with SIOPEL high-risk hepatoblastoma in Taiwan
Pediatrics and Neonatology, 2020 Backgorund: Hepatoblastoma is the most common primary liver malignancy in young children. Methods: To identify predictors of the clinical outcomes of hepatoblastoma, we retrospectively reviewed the medical records of 45 children with hepatoblastoma in ...
Wei-Yun Hsu +9 more
doaj +1 more source
Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: Impact on survival [PDF]
, 1992 Long-term survival in children with primary hepatic malignancies can not be expected without complete tumor resection. In the last ten years we have treated 21 children with hepatocellular carcinoma (HCC) and 21 children with hepatoblastoma (HEP), with ...
Iwatsuki, S +6 more
core +1 more source
Macromolecular Rapid Communications, EarlyView.Micellar systems based on biodegradable aliphatic polycarbonates and acid‐responsive triggers enhance drug solubility, stability, and tumor‐selective release. This review covers micelles with acid‐cleavable drug linkages and those that disassemble via acid‐sensitive functionalities.
Adrian V. Hauck, Lutz Nuhn
wiley +1 more source
Giant pedunculated hepatoblastoma mimicking neuroblastoma in a 4-month-old infant: a case report
BMC Pediatrics, 2023 Background Hepatoblastoma is the most common primary malignancy of hepatic origin in children, with an estimated incidence of 0.5–1.5 per million children.
Elham Zarei +3 more
doaj +1 more source
High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma. [PDF]
, 2017 Cancer may arise from dedifferentiation of mature cells or maturation-arrested stem cells. Previously we reported that definitive endoderm from which liver was derived, expressed Globo H, SSEA-3 and SSEA-4.
Ho, Ming-Yi +10 more
core +3 more sources
Medicinal Research Reviews, EarlyView.ABSTRACT CRISPR‐Cas9 genome‐wide screening has been instrumental towards identifying novel targets for drug discovery in cancer research. However, much of this research has centred specifically on adult cancers, with paediatric cancers being underserviced by current research and screening.
Steven He +2 more
wiley +1 more source